Researchers found that AI-driven decision support improved correct decision rates among emergency care doctors, but physician acceptance of AI recommendations remains split.
Key Details
- 1Study tested AI-enabled decision-support display ('DecAide') during pediatric trauma simulations with 35 ER care providers from six health systems.
- 2In scenarios with both AI information synthesis and recommendations, correct decisions were made 64.4% of the time, versus 56.3% with synthesis only and 55.8% with no AI support.
- 3Some clinicians accepted AI recommendations only after making their own decisions, while others distrusted or ignored the AI's output.
- 4AI did not slow down decision making; time to decision remained consistent across scenarios.
- 5Concerns about AI recommendations related to physician autonomy, potential bias, and a lack of transparency regarding the AI's reasoning.
- 6Findings were presented at the ACM Conference on Computer-Supported Cooperative Work & Social Computing, suggesting more research and clarity in AI adoption for emergency care.
Why It Matters
Although AI support is making inroads in certain fields, its use in time-sensitive clinical workflows like emergency medicine brings distinct challenges. Understanding when, how, and whether clinicians trust and benefit from AI recommendations is crucial for safe and effective integration of such tools in acute care environments and serves as a parallel lesson for radiology-AI system adoption.
Source
EurekAlert
Related News
•EurekAlert
AI-Driven CT Imaging Predicts Cardiac Events in Large UK Cohort
An AI tool analyzing CCTA images can predict future cardiovascular events and death in patients with suspected stable coronary artery disease.
•EurekAlert
AI Tool from UCLA Targets Undiagnosed Alzheimer's and Diagnostic Disparity
UCLA researchers developed an AI model using EHR data to better detect undiagnosed Alzheimer's disease, especially in underrepresented groups.
•EurekAlert
AI Multimodal Models Improve Breast Cancer Recurrence Risk Prediction
Initial results from an ECOG-ACRIN and Caris Life Sciences collaboration show AI-driven multimodal models can more accurately predict recurrence risk in early-stage breast cancer.